| pubmed-article:4008414 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:4008414 | lifeskim:mentions | umls-concept:C0024109 | lld:lifeskim |
| pubmed-article:4008414 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
| pubmed-article:4008414 | lifeskim:mentions | umls-concept:C0001924 | lld:lifeskim |
| pubmed-article:4008414 | lifeskim:mentions | umls-concept:C0013604 | lld:lifeskim |
| pubmed-article:4008414 | lifeskim:mentions | umls-concept:C0028928 | lld:lifeskim |
| pubmed-article:4008414 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
| pubmed-article:4008414 | lifeskim:mentions | umls-concept:C0450129 | lld:lifeskim |
| pubmed-article:4008414 | lifeskim:mentions | umls-concept:C0333668 | lld:lifeskim |
| pubmed-article:4008414 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:4008414 | pubmed:dateCreated | 1985-8-21 | lld:pubmed |
| pubmed-article:4008414 | pubmed:abstractText | Circulating fatty acids are normally transported principally bound to serum albumin. We examined whether administering oleic acid (OA) in a concentrated albumin solution would attenuate its edemogenic potential in the isolated dog lung lobe perfused with a solution nearly depleted of blood cellular and protein components. The isolated ventilated lower left lobe (LLL) was perfused (7.3 +/- 0.6 ml X min-1 X g LLL-1) with a balanced salt solution containing 6% dextran and approximately 10% serum (vol/vol). Hourly weight gain, net LLL weight gain, and wet-to-dry weight ratio (W/D) were used as indices of extravascular lung fluid changes. Group I lobes (n = 5) were given saline, whereas both group II (n = 5) and III (n = 5) lobes were administered 1 microliter OA/kg body wt. The OA was incubated with 5 ml of albumin solution containing approximately 640 mg of bovine fatty acid-free albumin before infusion into group III lobes. Group I gained weight at rate of 10.8 +/- 0.5 g X h-1 X 100 g LLL-1 after saline, whereas group II exhibited a greater (P less than 0.005) rate of weight gain of 42 +/- 13 after OA. Group III weight gain of 8.4 +/- 0.5 g X h-1 X 100 g LLL-1 was not different (P greater than 0.05) from group I but was lower (P less than 0.005) than group II.(ABSTRACT TRUNCATED AT 250 WORDS) | lld:pubmed |
| pubmed-article:4008414 | pubmed:language | eng | lld:pubmed |
| pubmed-article:4008414 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008414 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:4008414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4008414 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:4008414 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:4008414 | pubmed:issn | 8750-7587 | lld:pubmed |
| pubmed-article:4008414 | pubmed:author | pubmed-author:EhrhartI CIC | lld:pubmed |
| pubmed-article:4008414 | pubmed:author | pubmed-author:HofmanW FWF | lld:pubmed |
| pubmed-article:4008414 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:4008414 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:4008414 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:4008414 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:4008414 | pubmed:pagination | 1949-55 | lld:pubmed |
| pubmed-article:4008414 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:meshHeading | pubmed-meshheading:4008414-... | lld:pubmed |
| pubmed-article:4008414 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:4008414 | pubmed:articleTitle | Albumin attenuation of oleic acid edema in dog lung depleted of blood components. | lld:pubmed |
| pubmed-article:4008414 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:4008414 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
